drraut@icprm.in
+91-22-26671544 | 26671335
+91-98201 83757
01

Dr. Mrs. Mugdha Raut

Dr. Mrs. Mugdha Raut

Managing Director MD.DGO
Consultant Gynaecologist and obstetrician Gynaecologist Counseller

Learn More →
02

Dr. Mohan Raut

Dr. Mohan Raut

CEO MD. DGO
Consultant Gynaecologist and obstetrician

Learn More →
03

ICPRM

ICPRM

Donec ullamcorper nulla non metus auctor fringilla. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Aenean eu leo quam. Pellentesque ornare sem lacinia quam. Nulla vitae elit libero, a pharetra.

Learn More →

Repeated Miscarriages

Miscarriages/Repeated Miscarriages are amongst one of the most shattering experiences, a woman can go through. Statistics have shown that 25% of all pregnancies result in miscarriages.

IVF Failure

In Vitro Fertilization (IVF) is an Assisted Reproductive Technology, used in the treatment of Infertility. This involves taking out of the eggs from the ovaries, and fertilizing them with sperms in the laboratory.

What is LIT

Immunomodulation can play an important role in these patiets. Immunomodulatio can be done with Active or Passive Immunotherapy. Immunotherapy can help prevent the Immunological rejection of pregnancy.

Why LIT

ICPRM offers Immunotherapy Treatment to prevent recurrent miscarraiages. When a woman suffers from 2 or more miscarriages, it is termed as Repeated or Recurrent Miscarriages.

When LIT

Lymphocyte immunization Therapy holds much potential as a safe and effective treatment approach for patients who have failed IVF or repeated miscarriages.

LIT Benefits

  • High Success ratio
  • No long term side effects
  • Easy Treatment
  • Safe procedure
  • Single seating
  • Researched & patented technology
 
 
 

LIT Therapy

Lymphocyte Immunization Therapy

Features

Benefits

Sucess Rate

Adverse Effects

Features

Immunological response plays a very important role in maintenance of pregnancy. Many theories have been put forward to explain the mechanisms that help to protect pregnancy. Many allo-immune mechanisms have been described to explain the immunomodulatory effects of LIT. These mechanisms together or individually act on the feto-maternal interface to induce complex events preventing allo-immune rejection of pregnancy.

Benefits

– High Success ratio
– No long term side effects
– Easy Treatment
– Safe procedure
– Single seating
– Researched & patented technology

Sucess Rate

Total of 596 couples were given Immunotherapy, 486 patients with
Recurrent Miscarriages or unexplained infertility and 110 patients with IVF
implantation failure.
Of the 486 with RM, 390 women conceived and delivered live fetus at 33 weeks or later.
Of the 110 patients with IVF failure 85 conceived & delivered at 33
weeks or later

Adverse Effects

As LIT involves separation and injection of blood component (lymphocytes), establishing complete safety is important.

Systemic side effects : No systemic long term side effects have been reported. In 2006, Kling led large European studies, each involving over 4000 patients over a three year time span using LIT techniques. No anaphylaxis, autoimmune reactions or graft versus host disease were reported.
The safety issue that is commonly raised is transmission of infections, but with complete infection profile work-up of both the partners eliminates this risk.

1
Patent
50
Years Experience
75%
Success Ratio
600
LIT Treatments

What Clients Say